Swanson Chad J. sold (to issuer) $349K of PRTA
Swanson Chad J. (Chief Development Officer) sold (to issuer) 40,800 shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at $8.56 ($0.35M total) on 2026-07-28.
How this was made
The 30-second read
Why it matters
The newest fact is the specific insider sale size, price, and post-transaction holdings; the text provides no new company performance or guidance information.
Market read
Traders may treat this as low-signal insider activity unless paired with other company-specific catalysts.
What to watch
Code D indicates a sale to the issuer (often buyback participation or similar mechanics), which can be less informative than open-market selling.
Background
The article is a SEC Form 4 insider transaction disclosure for Prothena (PRTA).
Ticker impact
Prothena (PRTA) disclosed an insider Form 4 sale by its Chief Development Officer: 40,800 shares sold to the issuer at $8.56.
Low likelihood of a sustained price move based solely on this Form 4 sale.
The filing is a sale to the issuer (code D) with no 10b5-1 plan and no accompanying operational or financial catalyst in the text.
Market effects
Minimal, as the disclosure does not include clinical, regulatory, or financing updates.
None indicated.
None indicated.
Counterpoint
Even without a fundamental catalyst, the absence of a 10b5-1 plan could prompt traders to scrutinize insider intent.
Key entities
- issuerPROTHENA CORP PUBLIC LTD CO
Company subject of the Form 4 insider transaction disclosure.
- insiderSwanson Chad J.
Chief Development Officer who sold 40,800 shares to the issuer at $8.56 on 2026-07-28.